| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A joint model of longitudinal pharmacokinetic and time-to-event data to study exposure–response relationships: a proof-of-concept study with alectinib
|
Lin, Lishi
|
|
|
94 |
3 |
p. 453-459
|
artikel
|
| 2 |
AKR1C4 regulates the sensitivity of colorectal cancer cells to chemotherapy through ferroptosis modulation
|
Wang, Li
|
|
|
94 |
3 |
p. 373-385
|
artikel
|
| 3 |
Alterations in pharmacogenetic genes and their implications for imatinib resistance in Chronic Myeloid Leukemia patients from an admixed population
|
Cereja-Pantoja, Karla Beatriz Cardias
|
|
|
94 |
3 |
p. 387-395
|
artikel
|
| 4 |
A sub-pharmacological test dose does not predict individual docetaxel exposure in prostate cancer patients
|
Heerma van Voss, Marise R
|
|
|
94 |
3 |
p. 437-441
|
artikel
|
| 5 |
Comparable efficacy of oral bendamustine versus intravenous administration in treating hematologic malignancies
|
Cracchiolo, Megan J.
|
|
|
94 |
3 |
p. 361-372
|
artikel
|
| 6 |
Correction to: An IQ consortium analysis of starting dose selection for oncology small molecule first‑in‑patient trials suggests an alternative NOAEL‑based method can be safe while reducing time to the recommended phase 2 dose
|
Jessen, Bart A.
|
|
|
94 |
3 |
p. 1
|
artikel
|
| 7 |
Correction to: Inhibition of proteinase-activated receptor 2 (PAR2) decreased the malignant progression of lung cancer cells and increased the sensitivity to chemotherapy
|
Huo, Hongjie
|
|
|
94 |
3 |
p. 489
|
artikel
|
| 8 |
Correction to: Midostaurin drug interaction profile: a comprehensive assessment of CYP3A, CYP2B6, and CYP2C8 drug substrates, and oral contraceptives in healthy participants
|
Sechaud, Romain
|
|
|
94 |
3 |
p. 487
|
artikel
|
| 9 |
Correction to: Phase I study of the anti‑TIGIT antibody tiragolumab in combination with atezolizumab in Japanese patients with advanced or metastatic solid tumors
|
Yamamoto, Noboru
|
|
|
94 |
3 |
p. 491
|
artikel
|
| 10 |
Correction to: Up-regulation of autophagy is a mechanism of resistance to chemotherapy and can be inhibited by pantoprazole to increase drug sensitivity
|
Tan, Qian
|
|
|
94 |
3 |
p. 485-486
|
artikel
|
| 11 |
Development of a novel nomogram for predicting delayed methotrexate excretion following high-dose methotrexate in adult patients with hematologic malignancies
|
Ikeda, Daisuke
|
|
|
94 |
3 |
p. 397-406
|
artikel
|
| 12 |
Evaluation of the effect of modafinil on the pharmacokinetics of encorafenib and binimetinib in patients with BRAF V600-mutant advanced solid tumors
|
Piscitelli, Joseph
|
|
|
94 |
3 |
p. 337-347
|
artikel
|
| 13 |
Immunoregulatory cyclophilin a improves low-dose chemotherapy with a modulation of the immune tumor microenvironment in experimental models of melanoma B16 and lymphoma EL4 in vivo
|
Kalinina, Anastasiia A.
|
|
|
94 |
3 |
p. 407-420
|
artikel
|
| 14 |
Oral docetaxel plus encequidar – a phase 1 clinical trial
|
Wang, David
|
|
|
94 |
3 |
p. 475-481
|
artikel
|
| 15 |
Population pharmacokinetics of TLD-1, a novel liposomal doxorubicin, in a phase I trial
|
Mc Laughlin, Anna M.
|
|
|
94 |
3 |
p. 349-360
|
artikel
|
| 16 |
Postoperative chemotherapy relative dose intensity and overall survival in patients with colon cancer
|
Brown, Justin C.
|
|
|
94 |
3 |
p. 461-465
|
artikel
|
| 17 |
Preventive effect of free radical scavenger edaravone lotion on cyclophosphamide chemotherapy-induced alopecia
|
Tsuji, Takumi
|
|
|
94 |
3 |
p. 467-473
|
artikel
|
| 18 |
Quantitative characterization of the effects of fulvestrant alone or in combination with taselisib (PI3Kinase inhibitor) on longitudinal tumor growth in patients with estrogen receptor-positive, HER2-negative, PIK3CA-mutant, advanced or metastatic breast cancer
|
Moein, Anita
|
|
|
94 |
3 |
p. 421-436
|
artikel
|
| 19 |
Regorafenib plus FOLFIRINOX as first-line treatment for patients with RAS-mutant metastatic colorectal cancer (FOLFIRINOX-R trial): a dose-escalation study
|
Adenis, Antoine
|
|
|
94 |
3 |
p. 443-452
|
artikel
|
| 20 |
ZNF384 transcriptionally activated MGST1 to confer TMZ resistance of glioma cells by negatively regulating ferroptosis
|
Yan, Tengfeng
|
|
|
94 |
3 |
p. 323-336
|
artikel
|
Tijdschrift beschrijving